Salarius Pharmaceuticals Inc
For the period ended Mar 31, 2024. Filed May 13, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 13, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1A. Risk Factors
| Item 1A. | Risk Factors |
|---|
There have been no material changes in our risk factors set forth in Part I, “ Item 1A. Risk Factors” in our 2023 Form 10-K. The risk factors disclosed in Part I, “ Item 1A. Risk Factors” in our 2023 Form 10-K could materially adversely affect our business, financial condition, or results of operations. This Quarterly Report on Form 10-Q also contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including these risks. Additional risks not currently known or currently material to us may also harm our business.
No sales or issuances of unregistered securities occurred that have not previously been disclosed in a Current Report on Form 8-K.
| Item 3. | Defaults Upon Senior Securities |
|---|
None.
| Item 4. | Mine Safety Disclosures |
|---|
Not Applicable
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.